Skip to main content
RaySearch Laboratories logo

RaySearch Laboratories — Investor Relations & Filings

Ticker · RAY ISIN · SE0000135485 LEI · 549300TYFVYGS0JFWM28 ST Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 590 across all filing types
Latest filing 2012-10-23 Regulatory Filings
Country SE Sweden
Listing ST RAY

About RaySearch Laboratories

https://www.raysearchlabs.com/

RaySearch Laboratories develops advanced software solutions for radiation therapy and oncology. The company's product suite includes the RayStation® treatment planning system, the RayCare® oncology information system, and the RayIntelligence® oncology analytics system. These integrated platforms are engineered to enhance the efficiency, precision, and automation of cancer treatment workflows for clinics worldwide. By collaborating with leading cancer centers and research institutions, RaySearch aims to accelerate innovation in the field. The software is used by thousands of clinics to help clinicians plan and manage complex treatments, ultimately working to improve patient outcomes in the fight against cancer.

Recent filings

Filing Released Lang Actions
Rekordstor order på RayStation från ledande österrikiskt partikelterapicenter
Regulatory Filings Classification · 97% confidence The document is a press release dated October 23, 2012, announcing a significant order for the RayStation® planning system from a particle therapy center in Austria (MedAustron). It details the order value (exceeding 3.5 million euros), the technology involved (ion therapy, proton/carbon ion planning), and includes quotes from the CEOs of both companies. This type of announcement, detailing a major business contract or significant financial event outside of routine periodic reporting (like 10-K or IR), fits best under Capital/Financing Update (CAP) if it were about fundraising, or more generally as a significant business development announcement. Since it is a major contract win, it is not a standard regulatory filing (RNS) or an earnings release (ER). It is a specific business transaction announcement. Given the options, it is a significant business/contract announcement. It is not a standard regulatory filing like 10-K, IR, or ER. It is a press release announcing a major contract, which often falls under general business updates. Since there isn't a specific 'Major Contract Win' category, and it's not about financing (CAP), management change (MANG), or dividend (DIV), it is best classified as a general Regulatory Filing (RNS) as a catch-all for significant, non-standard announcements, or potentially a proxy for a major business event. However, looking closely at the definitions, it is a press release announcing a major business event (a large order). This is often categorized under RNS if no better fit exists. It is not a report itself, nor a management change, nor a financing event. RNS is the most appropriate fallback for a significant, non-standard press release.
2012-10-23 Swedish
RaySearch receives largest RayStation order to date from leading Austrian particle therapy center
Regulatory Filings Classification · 95% confidence The document is a press release dated October 23, 2012, announcing a significant business event: RaySearch receiving a large order for its RayStation® treatment planning system from MedAustron. It details the contract value (exceeding EUR 3.5 million), the nature of the technology (particle therapy, carbon ions), and includes quotes from both companies' CEOs. This type of announcement, detailing a major contract win or business development that is not a standard periodic financial report (like 10-K or IR) or a management change, falls best under a general business/regulatory announcement category. Since it is not a specific financial result (ER), management change (MANG), or capital activity (CAP), it fits best as a general Regulatory Filing (RNS) or potentially a general business update. Given the context of a press release announcing a major commercial contract, RNS (Regulatory News Service/General Regulatory Announcement) is the most appropriate fit among the provided options for a non-standard, material business disclosure.
2012-10-23 English
RaySearch licensierar teknologi för automatiserad dosplanering från Princess Margaret Cancer Centre
Regulatory Filings Classification · 96% confidence The document is a press release dated September 19, 2012, announcing that RaySearch Laboratories has entered into an exclusive licensing agreement with Princess Margaret Cancer Centre for technology related to automated dose planning. This announcement details a strategic business development, specifically the acquisition of rights to integrate new technology into their existing product (RayStation®). This type of announcement, concerning strategic partnerships, licensing deals, or significant business developments that are not standard periodic financial reports (like 10-K or IR) or management changes (MANG), fits best under a general business/regulatory announcement category. Since it is not a specific financial report, dividend notice, director dealing, or capital change, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for significant, non-standard corporate news releases.
2012-09-19 Swedish
RaySearch licenses technology for automated treatment planning from Princess Margaret Cancer Centre
Regulatory Filings Classification · 98% confidence The document is titled 'PRESS RELEASE' and announces an 'exclusive license agreement' regarding technology for automated treatment planning. It details a business transaction (licensing technology) between RaySearch Laboratories and Princess Margaret Cancer Centre. This type of announcement, which concerns strategic business development, partnerships, or technology commercialization, does not fit neatly into standard financial reporting categories like 10-K, ER, or IR. It is a specific corporate action announcement. Since there is no specific category for 'Technology Licensing Agreement' or 'Business Development Press Release', and it is not a standard regulatory filing like DIRS, DIV, or CAP (which usually involves raising capital or debt), the most appropriate fallback category is 'Regulatory Filings' (RNS) as a general corporate announcement that doesn't fit the other specific codes.
2012-09-19 English
First Coast Oncology väljer RayStation
Regulatory Filings Classification · 97% confidence The document is a press release dated September 18, 2012, announcing that First Coast Oncology has chosen RaySearch Laboratories' RayStation dosplanning system. This is a commercial announcement detailing a specific business transaction (an order/sale of technology) rather than a mandatory regulatory filing like a 10-K, an earnings release, or a management change. It does not fit the definitions for AGM-R, 10-K, AR, MANG, CT, DVA, DLST, DIRS, ER, SR, FS, CGR, IRAT, IR, IP, LTR, TAR, MRQ, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS. It is a specific business update regarding financing/capital structure changes (CAP) or a general regulatory announcement (RNS). Since it details a significant commercial contract/order, it is closest to a Capital/Financing Update (CAP) if interpreted broadly as a major business development, but given the options, it is most accurately classified as a general regulatory announcement or press release that doesn't fit a specific financial reporting category. However, since it is a press release announcing a major business event (a large order), and it is not a standard financial report, the most appropriate general category for non-standard, non-financial-report announcements is RNS (Regulatory Filings/General Announcement). If 'CAP' were strictly about the company raising capital, RNS is better. Given the context of a press release announcing a major customer win, RNS is the best fit as a catch-all for significant, non-standard corporate news.
2012-09-18 Swedish
First Coast Oncology selects RayStation
Regulatory Filings Classification · 97% confidence The document is a press release dated September 18, 2012, announcing that RaySearch Laboratories AB has received an order for its RayStation® treatment planning system from First Coast Oncology. This is a commercial announcement detailing a specific business transaction (a sale/order) and providing context about the involved parties and technology. It is not a mandatory regulatory filing like a 10-K, an earnings release (ER), or a formal capital/financing update (CAP). Since it describes a specific business development or contract, it fits best under the general category of Regulatory Filings (RNS) as a miscellaneous announcement, as there is no specific category for 'Commercial Contract Announcement' or 'Order Intake'. Given the options, RNS is the most appropriate fallback for a general press release about a business event that doesn't fit the highly specific financial or governance categories.
2012-09-18 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.